Clinical Trial Update: Trial to Evaluate the Safety and Efficacy of Keppra After Conversion to Mono-therapy in Subjects With Partial Epilepsy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the safety and efficacy of levetiracetam (Keppra) as monotherapy after conversion in subjects with partial epilepsy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial Epilepsy

Drugs mentioned

• Keppra (levetiracetam)

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsy | Phase 4 | Status: COMPLETED